Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 3;7(9):e2432245.
doi: 10.1001/jamanetworkopen.2024.32245.

Short-Term Exposure to Ambient Air Pollution and Antimicrobial Use for Acute Respiratory Symptoms

Affiliations

Short-Term Exposure to Ambient Air Pollution and Antimicrobial Use for Acute Respiratory Symptoms

Gabriela Abelenda-Alonso et al. JAMA Netw Open. .

Abstract

Importance: Ambient air pollution and antimicrobial resistance pose significant global public health challenges. It is not known whether ambient air pollution is associated with increased consumption of antimicrobials.

Objective: To assess whether a short-term association exists between ambient air pollution levels and antimicrobial consumption among the general population seeking primary care consultations for acute respiratory symptoms.

Design, setting, and participants: This 2-stage cross-sectional ecological time series analysis study using data on daily ambient air pollution and antimicrobial consumption was conducted in the 11 largest cities in Catalonia, Spain, from June 23, 2012, to December 31, 2019, among all inhabitants aged 12 years or older. Statistical analysis was performed from November 2022 to December 2023.

Exposures: Daily ambient air pollution (particulate matter of 10 μg/m3 [PM10], particulate matter of 2.5 μg/m3 [PM2.5], and nitrogen dioxide [NO2]).

Main outcomes and measures: The main outcome was antimicrobial consumption associated with primary care consultations for acute respiratory symptoms in the 30 days before and after the dispensing of the antimicrobial. Antimicrobial consumption was measured as defined daily doses (DDDs) per 1000 inhabitants per day.

Results: Among 1 938 333 inhabitants (median age, 48 years [IQR, 34-65 years]; 55% female participants), there were 8 421 404 antimicrobial dispensations, with a median of 12.26 DDDs per 1000 inhabitants per day (IQR, 6.03-15.32 DDDs per 1000 inhabitants per day). The median adjusted morbidity score was 2.0 (IQR, 1.0-5.0). For the 1 924 814 antimicrobial dispensations associated with primary care consultations for acute respiratory symptoms, there was a significant correlation between increases of 10 μg/m3 in the concentration of the 3 pollutants studied and heightened antimicrobial consumption at day 0 (PM10: relative risk [RR], 1.01 [95% CI, 1.01-1.02]; PM2.5: RR, 1.03 [95% CI, 1.01-1.04]; NO2: RR, 1.04 [95% CI, 1.03-1.05]). A delayed association emerged between increases in PM2.5 concentration and antimicrobial consumption between day 7 (RR, 1.00 [95% CI, 1.00-1.01]) and day 10 (RR, 1.00 [95% CI, 1.00-1.01]) after exposure.

Conclusions and relevance: In this 2-stage cross-sectional study using ecological time series analysis, short-term exposure to air pollution was associated with increased antimicrobial use associated with primary care consultations for acute respiratory symptoms in the general population. This finding could contribute to informing policy decisions aimed at reducing air pollution and its associated risks, thereby promoting respiratory health and reducing antimicrobial use.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Figures

Figure 1.
Figure 1.. Meta-Analysis of the Overall Estimated Risk of Increased Antimicrobial Consumption With Increases of 10 μg/m3 for Particulate Matter of 10 μg/m3 (PM10), Particulate Matter of 2.5 μg/m3 (PM2.5), and Nitrogen Dioxide (NO2)
Estimated relative risks (RRs) for an exposition to a 10-μg/m3 increase in air pollution on the day of exposure (day 0) to each pollutant (PM10, PM2.5, and NO2) and up to 14 days later, with 95% CIs. The overall estimate for the whole lag period is shown. The labels “Does not favor outcome” and “Favors outcome” both refer to antimicrobial use, with the outcome indicating an increase in antimicrobial consumption. The dashed vertical line indicates an RR of 1, corresponding to no association. The x-axis is logarithmically scaled.
Figure 2.
Figure 2.. Heatmap for Estimated Risks of Increased Antimicrobial Consumption With an Increase of 10 μg/m3 in the Particulate Matter of 10 μg/m3 (PM10), Particulate Matter of 2.5 μg/m3 (PM2.5), and Nitrogen Dioxide (NO2) for Each City
Heatmaps display the magnitude of the estimated relative risk (RR) for an exposition to a 10-μg/m3 increase in air pollution on the day of exposure (day 0) to each pollutant (PM10, PM2.5, and NO2) and up to 14 days later, for each city. Data for PM2.5 (panel B) were available for only 2 cities. The overall RR estimate for the whole lag period is shown for each city, with 95% CIs.

References

    1. Zhou Z, Shuai X, Lin Z, et al. . Association between particulate matter (PM)2·5 air pollution and clinical antibiotic resistance: a global analysis. Lancet Planet Health. 2023;7(8):e649-e659. doi:10.1016/S2542-5196(23)00135-3 - DOI - PubMed
    1. World Health Organization. WHO global air quality guidelines: particulate matter (PM2.5 and PM10), ozone, nitrogen dioxide, sulfur dioxide and carbon monoxide. 2021. World Health Organization. Accessed March 18, 2024. https://apps.who.int/iris/bitstream/handle/10665/345329/9789240034228-en... - PubMed
    1. Cohen AJ, Brauer M, Burnett R, et al. . Estimates and 25-year trends of the global burden of disease attributable to ambient air pollution: an analysis of data from the Global Burden of Diseases Study 2015. Lancet. 2017;389(10082):1907-1918. doi:10.1016/S0140-6736(17)30505-6 - DOI - PMC - PubMed
    1. Murray CJL, Aravkin AY, Zheng P, et al. ; GBD 2019 Risk Factors Collaborators . Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1223-1249. doi:10.1016/S0140-6736(20)30752-2 - DOI - PMC - PubMed
    1. Canova C, Dunster C, Kelly FJ, et al. . PM10-induced hospital admissions for asthma and chronic obstructive pulmonary disease: the modifying effect of individual characteristics. Epidemiology. 2012;23(4):607-615. doi:10.1097/EDE.0b013e3182572563 - DOI - PubMed

Publication types

MeSH terms